Arch Biopartners Inc. Stock Toronto S.E.
Equities
ARCH
CA03938C1041
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.68 CAD | -1.18% | +1.82% | +13.51% |
06-27 | Arch Biopartners Up More Than 2% After Announcing GMP Manufacturing Of Cilastatin Drug Product | MT |
06-27 | Arch Biopartners Inc. Announces GMP Manufacturing of Cilastatin Drug Product | CI |
Sales 2024 * | 2M 1.46M | Sales 2025 * | 2M 1.46M | Capitalization | 107M 77.96M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 53.3 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 53.3 x |
P/E ratio 2024 * |
-23.9
x | P/E ratio 2025 * |
-23.9
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 79.82% |
1 day | -1.18% | ||
1 week | +1.82% | ||
Current month | +0.60% | ||
3 months | -25.00% | ||
6 months | +17.48% | ||
Current year | +13.51% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Muruve
FOU | Founder | - | 83-03-03 |
Richard Muruve
FOU | Founder | - | 83-03-03 |
Andrew Bishop
DFI | Director of Finance/CFO | 58 | 10-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Rossman
BRD | Director/Board Member | - | 10-05-06 |
Richard Muruve
FOU | Founder | - | 83-03-03 |
Claude Allary
BRD | Director/Board Member | 69 | 14-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-28 | 1.68 | -1.18% | 6,100 |
24-06-27 | 1.7 | +3.03% | 11,300 |
24-06-26 | 1.65 | 0.00% | 13,927 |
24-06-25 | 1.65 | +1.85% | 4,000 |
24-06-24 | 1.62 | -1.82% | 23,996 |
Delayed Quote Toronto S.E., June 28, 2024 at 03:40 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.65% | 39.1B | |
-8.62% | 38.76B | |
+26.95% | 31.24B | |
+10.74% | 25.9B | |
-13.50% | 25.8B | |
+44.87% | 14.06B | |
+34.36% | 13.12B | |
-7.14% | 11.32B | |
-12.61% | 10.68B |
- Stock Market
- Equities
- ACHFF Stock
- ARCH Stock